{"disease":{"id":"craniopharyngiomas","name":"craniopharyngiomas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06970145","title":"Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02860923","title":"Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}